Maurice O’Kane

Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 3K citations · Full text

Medicine, Endocrinology, Pharmacology +14

Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 629 citations · Full text

Medicine, Endocrinology, Nephrology +15

Efficacy of self monitoring of blood glucose in patients with newly diagnosed type 2 diabetes (ESMON study): randomised controlled trial

Maurice O’Kane, Brendan Bunting, M Copeland et al. · BMJ · 2008 · 327 citations · Full text

Medicine, Endocrinology, Health Education +17

Quality Indicators in Laboratory Medicine: from theory to practice

Laura Sciacovelli, Maurice O’Kane, Younis Abdelwahab Skaik et al. · Clinical Chemistry and Laboratory Medicine (CCLM) · 2011 · 133 citations

Health Professions, Quality Management, Healthcare Quality Improvement +16

Treatment of Diabetic Ketoacidosis Using Normalization of Blood 3-Hydroxybutyrate Concentration as the Endpoint of Emergency Management: A randomized controlled study

M Ivan Wiggam, Maurice O’Kane, Roy Harper et al. · Diabetes Care · 1997 · 103 citations

Medicine, Endocrinology, Pharmacology +17